Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2006 Oct;19(4):637-57.
doi: 10.1128/CMR.00051-05.

Ventilator-associated pneumonia: diagnosis, treatment, and prevention

Steven M Koenig  1 , Jonathon D Truwit
Affiliations
Practice Guideline

Ventilator-associated pneumonia: diagnosis, treatment, and prevention

Steven M Koenig et al. Clin Microbiol Rev. 2006 Oct.

Abstract

While critically ill patients experience a life-threatening illness, they commonly contract ventilator-associated pneumonia. This nosocomial infection increases morbidity and likely mortality as well as the cost of health care. This article reviews the literature with regard to diagnosis, treatment, and prevention. It provides conclusions that can be implemented in practice as well as an algorithm for the bedside clinician and also focuses on the controversies with regard to diagnostic tools and approaches, treatment plans, and prevention strategies.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Algorithm for diagnosis and treatment of VAP. (©American Thoracic Society. Adapted from the American Journal of Respiratory and Critical Care Medicine [5] with permission.) Antibiotic choice can be tailored to the pathogens’ last sensitivity report should QEA surveillance cultures be obtained twice weekly and should the growth level exceed 100,000 CFU/ml (.)
FIG. 2.
FIG. 2.
Pharmacodynamic and pharmokinetic approach to antibiotic therapy.
FIG. 3.
FIG. 3.
Potential strategies to prevent VAP.
See this image and copyright information in PMC

References

    1. Abele-Horn, M., A. Dauber, A. Bauernfeind, W. Russwurm, I. Seyfarth-Metzger, P. Gleich, and G. Ruckdeschel. 1997. Decrease in nosocomial pneumonia in ventilated patients by selective oropharyngeal decontamination (SOD). Intensive Care Med. 23:187-195. - PubMed
    1. Alvarez-Lerma, F., et al. 1996. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. Intensive Care Med. 22:387-394. - PubMed
    1. Ambrose, P. G., D. M. Grasela, T. H. Grasela, J. Passarell, H. B. Mayer, and P. F. Pierce. 2001. Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections. Antimicrob. Agents Chemother. 45:2793-2797. - PMC - PubMed
    1. Ambrose, P. G., R. C. Owens, Jr., M. J. Garvey, and R. N. Jones. 2002. Pharmacodynamic considerations in the treatment of moderate to severe pseudomonal infections with cefepime. J. Antimicrob. Chemother. 49:445-453. - PubMed
    1. American Thoracic Society. 2005. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am. J. Respir. Crit. Care Med. 171:388-416. - PubMed

Publication types

MeSH terms